prednisolone has been researched along with Bloch-Siemens Syndrome in 2 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogasawara, K | 1 |
| Honda, Y | 1 |
| Maeda, H | 1 |
| Sato, M | 1 |
| Nakano, H | 1 |
| Hosoya, M | 1 |
| BETTECKEN, F | 1 |
2 other studies available for prednisolone and Bloch-Siemens Syndrome
| Article | Year |
|---|---|
Corticosteroid Therapy in Neonatal Incontinentia Pigmenti With Asymptomatic Cerebral Lesions.
Topics: Anti-Inflammatory Agents; Female; Frontal Lobe; Humans; I-kappa B Kinase; Incontinentia Pigmenti; In | 2019 |
[EARLY STAGE OF INCONTINENTIA PIGMENTI (BLOCH-SULZBERGER) AND CORTICOSTEROID TREATMENT].
Topics: Adrenal Cortex Hormones; Child; Genetics, Medical; Humans; Incontinentia Pigmenti; Infant; Infant, N | 1963 |